0001564590-21-056777.txt : 20211115 0001564590-21-056777.hdr.sgml : 20211115 20211115060330 ACCESSION NUMBER: 0001564590-21-056777 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20211115 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20211115 DATE AS OF CHANGE: 20211115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Syneos Health, Inc. CENTRAL INDEX KEY: 0001610950 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 273403111 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 211405977 BUSINESS ADDRESS: STREET 1: 1030 SYNC STREET CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-876-9300 MAIL ADDRESS: STREET 1: 1030 SYNC STREET CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: INC Research Holdings, Inc. DATE OF NAME CHANGE: 20140616 8-K 1 synh-8k_20211115.htm 8-K synh-8k_20211115.htm
false 0001610950 0001610950 2021-11-15 2021-11-15

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 15, 2021

 

SYNEOS HEALTH, INC.

(Exact name of registrant as specified in its charter)

 

 

Delaware

001-36730

27-3403111

(State or other jurisdiction
of incorporation)

(Commission
File Number)

(IRS Employer
Identification No.)

 

1030 Sync Street

Morrisville, North Carolina

27560-5468

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (919) 876-9300

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Class A Common Stock,
$0.01 par value per share

 

SYNH

 

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐   

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section

13(a) of the Exchange Act.  ☐

 

 

Item 7.01 Regulation FD Disclosure.

Syneos Health, Inc. (the “Company”) continually reviews and evaluates strategic business opportunities with a focus on enhancing stockholder value. At this time, the Company is not engaged in discussions with respect to, or activities in furtherance of, a potential business combination or transaction with Laboratory Corporation of America Holdings or any of its businesses or divisions.

The information in this Item 7.01 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Forward-Looking Statements

Except for historical information, all of the statements, expectations, and assumptions contained in this Current Report on Form 8-K are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s ongoing evaluation of strategic business opportunities. Actual results may differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include, but are not limited to, changes in business conditions and other risk factors set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and other SEC filings, copies of which are available free of charge on the Company’s website at investor.syneoshealth.com. The Company assumes no obligation and does not intend to update these forward-looking statements, except as required by law.

 

 

 

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

SYNEOS HEALTH, INC.

 

 

 

 

 

Date:

November 15, 2021

By:

/s/ Jonathan Olefson

 

 

 

Name:

Jonathan Olefson

 

 

 

Title:

General Counsel and Corporate Secretary

 

 

 EX-101.SCH 2 synh-20211115.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 synh-20211115_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Cover [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Emerging Growth Company Entity Emerging Growth Company Entity File Number Entity File Number Entity Incorporation State Country Code Entity Incorporation State Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address Address Line1 Entity Address, City or Town Entity Address City Or Town Entity Address, State or Province Entity Address State Or Province Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name EX-101.PRE 4 synh-20211115_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 synh-8k_20211115_htm.xml IDEA: XBRL DOCUMENT 0001610950 2021-11-15 2021-11-15 false 0001610950 8-K 2021-11-15 SYNEOS HEALTH, INC. DE 001-36730 27-3403111 1030 Sync Street Morrisville NC 27560-5468 (919) 876-9300 false false false false Class A Common Stock,$0.01 par value per share SYNH NASDAQ false XML 6 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Document and Entity Information
Nov. 15, 2021
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Nov. 15, 2021
Entity Registrant Name SYNEOS HEALTH, INC.
Entity Central Index Key 0001610950
Entity Emerging Growth Company false
Entity File Number 001-36730
Entity Incorporation State Country Code DE
Entity Tax Identification Number 27-3403111
Entity Address, Address Line One 1030 Sync Street
Entity Address, City or Town Morrisville
Entity Address, State or Province NC
Entity Address, Postal Zip Code 27560-5468
City Area Code (919)
Local Phone Number 876-9300
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Class A Common Stock,$0.01 par value per share
Trading Symbol SYNH
Security Exchange Name NASDAQ
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 1 96 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.syneoshealth.com/20211115/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports synh-8k_20211115.htm synh-20211115.xsd synh-20211115_lab.xml synh-20211115_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "synh-8k_20211115.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "synh-8k_20211115.htm" ] }, "labelLink": { "local": [ "synh-20211115_lab.xml" ] }, "presentationLink": { "local": [ "synh-20211115_pre.xml" ] }, "schema": { "local": [ "synh-20211115.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "synh", "nsuri": "http://www.syneoshealth.com/20211115", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "synh-8k_20211115.htm", "contextRef": "C_0001610950_20211115_20211115", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.syneoshealth.com/20211115/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "synh-8k_20211115.htm", "contextRef": "C_0001610950_20211115_20211115", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.syneoshealth.com/20211115/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.syneoshealth.com/20211115/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.syneoshealth.com/20211115/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.syneoshealth.com/20211115/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line1", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.syneoshealth.com/20211115/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.syneoshealth.com/20211115/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.syneoshealth.com/20211115/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.syneoshealth.com/20211115/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.syneoshealth.com/20211115/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.syneoshealth.com/20211115/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.syneoshealth.com/20211115/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.syneoshealth.com/20211115/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.syneoshealth.com/20211115/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.syneoshealth.com/20211115/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.syneoshealth.com/20211115/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.syneoshealth.com/20211115/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.syneoshealth.com/20211115/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.syneoshealth.com/20211115/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.syneoshealth.com/20211115/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.syneoshealth.com/20211115/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.syneoshealth.com/20211115/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.syneoshealth.com/20211115/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 13 0001564590-21-056777-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-21-056777-xbrl.zip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